Inhibitor potencies and substrate preference for endothelin-converting enzyme-1 are dramatically affected by pH

被引:11
|
作者
Fahnoe, DC [1 ]
Knapp, J [1 ]
Johnson, GD [1 ]
Ahn, K [1 ]
机构
[1] Parke Davis Pharmaceut Res, Dept Biochem, Ann Arbor, MI 48105 USA
关键词
endothelin-converting enzyme-1 (ECE-1); endothelin (ET); pH-dependence; pH optimum;
D O I
10.1097/00005344-200036001-00009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Phosphoramidon has been shown to inhibit endothelin-converting enzyme-1 (ECE-1) in a remarkably pH-dependent manner (Ahn et al. Arch Biochem Biophys 1998;359:258-68), In order to determine whether this dramatic pH-dependence is a general phenomenon of ECE-1, two structurally unrelated ECE-1 inhibitors, PD 069185 and CGS 31447, were tested for ECE-1 inhibition at various pH values. Our data indicate that the potencies of these ECE-1 inhibitors are also highly affected by pH. ECE-1 is known to have a very sharp activity optimum at neutral pH which is in marked contrast to the acidic pH optimum for ECE-2. However, our results show that the pH optimum for ECE-1 activity is highly substrate-dependent. ECE-1 hydrolyzes the small peptide hormones bradykinin and substance P with acidic pH optima of 5.6-5.8, which sharply contrasts the neutral pH optimum with big ET-1 as substrate. These data suggest that the substrate preference for ECE-1 is highly affected by pH and that this pH-dependence for substrate preference might be one way of controlling the specificity of the enzyme in vivo.
引用
收藏
页码:S22 / S25
页数:4
相关论文
共 50 条
  • [1] Endothelin-converting enzyme-1 in cancer aggressiveness
    Tapia, Julio C.
    Niechi, Ignacio
    CANCER LETTERS, 2019, 452 : 152 - 157
  • [2] Development of an internally quenched fluorescent substrate selective for endothelin-converting enzyme-1
    Johnson, GD
    Ahn, K
    ANALYTICAL BIOCHEMISTRY, 2000, 286 (01) : 112 - 118
  • [3] PURIFICATION AND CHARACTERIZATION OF RECOMBINANT ENDOTHELIN-CONVERTING ENZYME-1
    EMOTO, N
    TAKEDA, S
    YANAGISAWA, M
    CIRCULATION, 1995, 92 (08) : 3043 - 3043
  • [4] Placental endothelin-converting enzyme-1 is decreased in preeclampsia
    McCormick, Anna
    Kristianto, Jasmin
    Wang, Xiaohu
    McIntosh, Jennifer
    Cruz, Meredith
    Hibbard, Judith U.
    Blank, Robert D.
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2020, 20 : 108 - 110
  • [5] Localization of endothelin-converting enzyme-1 in human kidney
    Pupilli, C
    Romagnani, P
    Lasagni, L
    Bellini, F
    Misciglia, N
    Emoto, N
    Yanagisawa, M
    Rizzo, M
    Mannelli, M
    Serio, M
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1997, 273 (05) : F749 - F756
  • [6] Functional significance of the isoforms of endothelin-converting enzyme-1
    Brown, CD
    Barnes, K
    Turner, AJ
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 : S26 - S27
  • [7] Big endothelin analogues with inhibitory activity on endothelin-converting enzyme-1
    Takayanagi, R
    Liu, W
    Ito, T
    Ohnaka, K
    Nawata, H
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S62 - S63
  • [8] Characterization of PgPepO, a bacterial homologue of endothelin-converting enzyme-1
    Carson, JA
    Ansai, T
    Awano, S
    Yu, WX
    Takehara, T
    Turner, AJ
    CLINICAL SCIENCE, 2002, 103 : 90S - 93S
  • [9] Monoclonal antibodies against human endothelin-converting enzyme-1
    Subkowski, T
    Hillen, H
    Kröger, B
    Schmidt, M
    JOURNAL OF IMMUNOASSAY, 1998, 19 (2-3): : 75 - 93
  • [10] IDENTIFICATION AND CHARACTERIZATION OF 2 ISOFORMS OF AN ENDOTHELIN-CONVERTING ENZYME-1
    SHIMADA, K
    TAKAHASHI, M
    IKEDA, M
    TANZAWA, K
    FEBS LETTERS, 1995, 371 (02) : 140 - 144